M. C. Genovese

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Graeme Jones, Anthony Sebba, Jianhui Gu et al. · Annals of the Rheumatic Diseases · 2009 · 809 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study

M. C. Genovese, Joel M. Kremer, Omid Zamani et al. · Annals of the Rheumatic Diseases · 2015 · 27 citations

Medicine, Pharmacology, Pharmacotherapy +14

Lemierreʼs Syndrome

Fred A. Lopez, M. C. Genovese, J. Loutit · Southern Medical Journal · 1997 · 27 citations

Medicine, Infectious Diseases, Internal Medicine +17

24-Week Results of a Blinded Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Januse Kinase 2 Inhibitor, in Combination with Traditional Disease Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis.

M. C. Genovese, Ed Keystone, P. W. J. Taylor et al. · Oxford University Research Archive (ORA) (University of Oxford) · 2012 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +16

OP0121 Enbrel® (etanercept) vs. methotrexate (mtx) in early rheumatoid arthritis (era trial): two-year follow-up

M. C. Genovese, RW Martin, Roy Fleischmann et al. · Annals of the Rheumatic Diseases · 2001 · 15 citations

Medicine, Internal Medicine, Pharmacotherapy +15